COVID-19 Clinical Trials in Houston

Showing 141-160 of 201 trials

Anti-SARS Cov-2 T Cell Infusions for COVID 19

NCT04401410

This is a dose-finding safety trial followed by a randomized pilot trial comparing administration of SARS-CoV2-specific T cells (SARS-CoVSTs) to standard of care treatment in hospitalized patients with COVID19 who are at high risk of requiring mechanical ventilation. The SARS-CoVSTs lines have been made at Baylor College of Medicine from healthy donors who have made a full recovery from COVID19. These cell lines were frozen for later use and will be thawed and used to treat patients who meet the eligibility criteria.

SARS-CoV 2Viral InfectionCOVID 19

Baylor College of Medicine4 participantsStarted Nov 2020

Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

NCT04363736

This study will assess the pharmacodynamics, pharmacokinetics, safety and efficacy of two different doses of tocilizumab (TCZ) in combination with standard-of-care (SOC) in hospitalized adult participants with moderate to severe COVID-19 pneumonia.

COVID-19 Pneumonia

Hoffmann-La Roche97 participantsStarted May 2020

Phoenix, Arizona, United States • Fullerton, California, United States • Los Angeles, California, United States +21 more locations

Anti-SARS Cov-2 T Cell Infusions for COVID 19

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

COVID-19 Trials in Other Cities

Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients

Dapagliflozin in Respiratory Failure in Patients With COVID-19

Convalescent Plasma to Stem Coronavirus (CSSC-001)

Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19

SARS-CoV-2 OTC At Home Test

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants

Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise

A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19

CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19

Treatment for COVID-19 in High-Risk Adult Outpatients

A Study of Immune Responses to the Virus That Causes COVID-19

Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients

COVID-19 Vaccines Safety Tracking (CoVaST)

Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19

Low-Level Laser Therapy Treatment of Lung Inflammation in Post-COVID-19 Recovery

Other Conditions in Houston